— Know what they know.
Not Investment Advice
Also trades as: 0JZU.L (LSE) · $vol 0M

MCK NYSE

McKesson Corporation
1W: -6.1% 1M: +12.9% 3M: +8.8% YTD: +17.5% 1Y: +20.7% 3Y: +115.8% 5Y: +388.3%
$967.02
-25.85 (-2.60%)
 
Weekly Expected Move ±3.6%
$928 $965 $1001 $1037 $1073
NYSE · Healthcare · Medical - Distribution · Tech Score Buy · Power 74 · $112.7B mcap · 117M float · 0.821% daily turnover · Short 40% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 9.4% of company value Bonds: $249.8M held by 162 funds, 50 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $6.39 (down 99.3%), McKesson Corporation would be worth roughly what it owes.
Total debt $11.70B against a stock market value of $112.75B.
Distance to default 10.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $5.51B (short-term plus half of long-term), stock volatility 30.4%; Altman Z'' 0.74. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Supply Chain Overview

3 relationships
0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2022-03-04
Earliest Filing
2022-05-03
Latest Filing

Mentioned As Counterparty

3 mentions

Other companies that named MCK in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
COR AMERISOURCEBERGEN CORP partner Settling Distributor in opioid-related lawsuit settlement 2022-05-03 View
SCNX TRxADE HEALTH, INC target McKesson Corporation is the beneficiary of the guaranty and the creditor extending credit to the Debtor. 2022-03-11 View
SCNX TRxADE HEALTH, INC target McKesson Corporation is the beneficiary of the guaranty and the entity extending credit to the Debtor. 2022-03-04 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-06 Regulation FD; Exhibits View
2026-08-28 Regulation FD; Exhibits View
2026-08-05 Earnings Release; Exhibits View
2026-07-24 Shareholder Vote View
2026-07-01 Officer/Director Change; Regulation FD; Exhibits View
2026-06-12 Material Agreement; Financial Obligation; Exhibits Agreement View
2026-05-07 Earnings Release; Exhibits View
2026-04-28 Material Agreement; Termination of Agreement; Financial Obligation; Exhibits Agreement View
2026-04-06 Material Agreement; Financial Obligation; Exhibits Agreement View
2026-03-06 Regulation FD Disclosure; Financial Statements and Exhibits View
2026-03-05 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2026-02-04 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-23 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-09-18 Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits View
2025-08-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-01 Submission of Matters to a Vote of Security Holders View
2025-06-09 Regulation FD Disclosure View
2025-05-30 Creation of Direct Financial Obligation; Other Events; Financial Statements and Exhibits View
2025-05-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms